Disclaimer:

Medidex is not a provider of medical services and all information is provided for the convenience of the user. No medical decisions should be made based on the information provided on this website without first consulting a licensed healthcare provider.This website is intended for persons 18 years or older. No person under 18 should consult this website without the permission of a parent or guardian.

Dextroamphetamine SulfateExtended-Release

×

Overview

What is Dextroamphetamine SulfateExtended-Release?

Dextroamphetamine sulfate is the dextro isomer of the compound -amphetamine sulfate, a sympathomimetic amine of the amphetamine group. Chemically, dextroamphetamine is -alpha-methylphenethylamine, and is present in all forms of dextroamphetamine sulfate as the neutral sulfate.

Structural formula:

Each extended-release capsule is so prepared that an initial dose is released promptly and the remaining medication is released gradually over a prolonged period. Each small spherical capsule, contains dextroamphetamine sulfate. The 5 mg capsule is imprinted “327” on the YELLOW cap, and “CP” and “5 mg” on the body. The 10 mg capsule is imprinted “328” on the ORANGE cap, and “CP” and “10 mg” on the body. The 15 mg capsule is imprinted “329” on the RED cap, and “CP” and “15 mg” on the body. Product reformulation in 1996 has caused a minor change in the color of the time-released pellets within each capsule. Inactive ingredients now consist of cetyl alcohol, D&C Yellow No. 10, dibutyl sebacate, ethylcellulose, FD&C Red No. 40, FD&C Yellow No. 6, gelatin, hypromellose, polyethylene glycol, povidone, sodium lauryl sulfate, sugar spheres, and trace amounts of other inactive ingredients.



What does Dextroamphetamine SulfateExtended-Release look like?



What are the available doses of Dextroamphetamine SulfateExtended-Release?

Sorry No records found.

What should I talk to my health care provider before I take Dextroamphetamine SulfateExtended-Release?

Sorry No records found

How should I use Dextroamphetamine SulfateExtended-Release?

Dextroamphetamine sulfate is indicated in:

Amphetamines should be administered at the lowest effective dosage and dosage should be individually adjusted. Late evening doses should be avoided because of the resulting insomnia.


What interacts with Dextroamphetamine SulfateExtended-Release?

Sorry No Records found


What are the warnings of Dextroamphetamine SulfateExtended-Release?

Sorry No Records found


What are the precautions of Dextroamphetamine SulfateExtended-Release?

Sorry No Records found


What are the side effects of Dextroamphetamine SulfateExtended-Release?

Sorry No records found


What should I look out for while using Dextroamphetamine SulfateExtended-Release?

Advanced arteriosclerosis, symptomatic cardiovascular disease, moderate to severe hypertension, hyperthyroidism, known hypersensitivity or idiosyncrasy to the sympathomimetic amines, glaucoma.Agitated states.Patients with a history of drug abuse.Known hypersensitivity or idiosyncrasy to amphetamine.In patients known to be hypersensitive to amphetamine, or other components of dextroamphetamine sulfate. Hypersensitivity reactions such as angioedema and anaphylactic reactions have been reported in patients treated with other amphetamine products [see Adverse Reactions]

Patients taking monoamine oxidase inhibitors (MAOIs), or within 14 days of stopping MAOIs (including MAOIs such as linezolid or intravenous methylene blue), because of an increased risk of hypertensive crisis [see Warnings and Drug Interactions].


What might happen if I take too much Dextroamphetamine SulfateExtended-Release?

Manifestations of amphetamine overdose include restlessness, tremor, hyperreflexia, rapid respiration, confusion, assaultiveness, hallucinations, panic states, hyperpyrexia and rhabdomyolysis. Fatigue and depression usually follow the central nervous system stimulation. Serotonin syndrome has also been reported. Cardiovascular effects include arrhythmias, hypertension or hypotension and circulatory collapse. Gastrointestinal symptoms include nausea, vomiting, diarrhea and abdominal cramps. Fatal poisoning is usually preceded by convulsions and coma.

Treatment

Consult with a Certified Poison Control Center for up to date guidance and advice.

 


How should I store and handle Dextroamphetamine SulfateExtended-Release?

Store ADASUVE at room temperature, 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. Keep out of reach of children.Keep ADASUVE in pouch until time of use. ADASUVE contains a lithium battery. Dispose of ADASUVE in accordance with all federal, state and local laws.Store ADASUVE at room temperature, 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. Keep out of reach of children.Keep ADASUVE in pouch until time of use. ADASUVE contains a lithium battery. Dispose of ADASUVE in accordance with all federal, state and local laws.Store ADASUVE at room temperature, 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. Keep out of reach of children.Keep ADASUVE in pouch until time of use. ADASUVE contains a lithium battery. Dispose of ADASUVE in accordance with all federal, state and local laws.Store ADASUVE at room temperature, 15° to 30°C (59° to 86°F) [see USP Controlled Room Temperature]. Keep out of reach of children.Keep ADASUVE in pouch until time of use. ADASUVE contains a lithium battery. Dispose of ADASUVE in accordance with all federal, state and local laws.Dextroamphetamine Sulfate Extended-Release Capsules are supplied as follows:Dextroamphetamine Sulfate Extended-Release Capsules, 5 mg: “327”“CP”“5 mg”Dextroamphetamine Sulfate Extended-Release Capsules, 10 mg: “328”“CP”“10 mg”Dextroamphetamine Sulfate Extended-Release Capsules, 15 mg: “329”“CP”“15 mg”Store at controlled room temperature between 20° to 25°C (68° to 77°F) [See USP].Dispense in a tight, light-resistant container.Manf. by:Catalent Pharma SolutionsWinchester, KY 40391 Dist. by:Impax GenericsHayward, CA 94544Rev. May, 2017For additional copies of the printed patient information/medication guide, please visit www.impaxlabs.com or contact us at 1-800-934-6729.Dextroamphetamine Sulfate Extended-Release Capsules are supplied as follows:Dextroamphetamine Sulfate Extended-Release Capsules, 5 mg: “327”“CP”“5 mg”Dextroamphetamine Sulfate Extended-Release Capsules, 10 mg: “328”“CP”“10 mg”Dextroamphetamine Sulfate Extended-Release Capsules, 15 mg: “329”“CP”“15 mg”Store at controlled room temperature between 20° to 25°C (68° to 77°F) [See USP].Dispense in a tight, light-resistant container.Manf. by:Catalent Pharma SolutionsWinchester, KY 40391 Dist. by:Impax GenericsHayward, CA 94544Rev. May, 2017For additional copies of the printed patient information/medication guide, please visit www.impaxlabs.com or contact us at 1-800-934-6729.Dextroamphetamine Sulfate Extended-Release Capsules are supplied as follows:Dextroamphetamine Sulfate Extended-Release Capsules, 5 mg: “327”“CP”“5 mg”Dextroamphetamine Sulfate Extended-Release Capsules, 10 mg: “328”“CP”“10 mg”Dextroamphetamine Sulfate Extended-Release Capsules, 15 mg: “329”“CP”“15 mg”Store at controlled room temperature between 20° to 25°C (68° to 77°F) [See USP].Dispense in a tight, light-resistant container.Manf. by:Catalent Pharma SolutionsWinchester, KY 40391 Dist. by:Impax GenericsHayward, CA 94544Rev. May, 2017For additional copies of the printed patient information/medication guide, please visit www.impaxlabs.com or contact us at 1-800-934-6729.Dextroamphetamine Sulfate Extended-Release Capsules are supplied as follows:Dextroamphetamine Sulfate Extended-Release Capsules, 5 mg: “327”“CP”“5 mg”Dextroamphetamine Sulfate Extended-Release Capsules, 10 mg: “328”“CP”“10 mg”Dextroamphetamine Sulfate Extended-Release Capsules, 15 mg: “329”“CP”“15 mg”Store at controlled room temperature between 20° to 25°C (68° to 77°F) [See USP].Dispense in a tight, light-resistant container.Manf. by:Catalent Pharma SolutionsWinchester, KY 40391 Dist. by:Impax GenericsHayward, CA 94544Rev. May, 2017For additional copies of the printed patient information/medication guide, please visit www.impaxlabs.com or contact us at 1-800-934-6729.Dextroamphetamine Sulfate Extended-Release Capsules are supplied as follows:Dextroamphetamine Sulfate Extended-Release Capsules, 5 mg: “327”“CP”“5 mg”Dextroamphetamine Sulfate Extended-Release Capsules, 10 mg: “328”“CP”“10 mg”Dextroamphetamine Sulfate Extended-Release Capsules, 15 mg: “329”“CP”“15 mg”Store at controlled room temperature between 20° to 25°C (68° to 77°F) [See USP].Dispense in a tight, light-resistant container.Manf. by:Catalent Pharma SolutionsWinchester, KY 40391 Dist. by:Impax GenericsHayward, CA 94544Rev. May, 2017For additional copies of the printed patient information/medication guide, please visit www.impaxlabs.com or contact us at 1-800-934-6729.Dextroamphetamine Sulfate Extended-Release Capsules are supplied as follows:Dextroamphetamine Sulfate Extended-Release Capsules, 5 mg: “327”“CP”“5 mg”Dextroamphetamine Sulfate Extended-Release Capsules, 10 mg: “328”“CP”“10 mg”Dextroamphetamine Sulfate Extended-Release Capsules, 15 mg: “329”“CP”“15 mg”Store at controlled room temperature between 20° to 25°C (68° to 77°F) [See USP].Dispense in a tight, light-resistant container.Manf. by:Catalent Pharma SolutionsWinchester, KY 40391 Dist. by:Impax GenericsHayward, CA 94544Rev. May, 2017For additional copies of the printed patient information/medication guide, please visit www.impaxlabs.com or contact us at 1-800-934-6729.Dextroamphetamine Sulfate Extended-Release Capsules are supplied as follows:Dextroamphetamine Sulfate Extended-Release Capsules, 5 mg: “327”“CP”“5 mg”Dextroamphetamine Sulfate Extended-Release Capsules, 10 mg: “328”“CP”“10 mg”Dextroamphetamine Sulfate Extended-Release Capsules, 15 mg: “329”“CP”“15 mg”Store at controlled room temperature between 20° to 25°C (68° to 77°F) [See USP].Dispense in a tight, light-resistant container.Manf. by:Catalent Pharma SolutionsWinchester, KY 40391 Dist. by:Impax GenericsHayward, CA 94544Rev. May, 2017For additional copies of the printed patient information/medication guide, please visit www.impaxlabs.com or contact us at 1-800-934-6729.Dextroamphetamine Sulfate Extended-Release Capsules are supplied as follows:Dextroamphetamine Sulfate Extended-Release Capsules, 5 mg: “327”“CP”“5 mg”Dextroamphetamine Sulfate Extended-Release Capsules, 10 mg: “328”“CP”“10 mg”Dextroamphetamine Sulfate Extended-Release Capsules, 15 mg: “329”“CP”“15 mg”Store at controlled room temperature between 20° to 25°C (68° to 77°F) [See USP].Dispense in a tight, light-resistant container.Manf. by:Catalent Pharma SolutionsWinchester, KY 40391 Dist. by:Impax GenericsHayward, CA 94544Rev. May, 2017For additional copies of the printed patient information/medication guide, please visit www.impaxlabs.com or contact us at 1-800-934-6729.Dextroamphetamine Sulfate Extended-Release Capsules are supplied as follows:Dextroamphetamine Sulfate Extended-Release Capsules, 5 mg: “327”“CP”“5 mg”Dextroamphetamine Sulfate Extended-Release Capsules, 10 mg: “328”“CP”“10 mg”Dextroamphetamine Sulfate Extended-Release Capsules, 15 mg: “329”“CP”“15 mg”Store at controlled room temperature between 20° to 25°C (68° to 77°F) [See USP].Dispense in a tight, light-resistant container.Manf. by:Catalent Pharma SolutionsWinchester, KY 40391 Dist. by:Impax GenericsHayward, CA 94544Rev. May, 2017For additional copies of the printed patient information/medication guide, please visit www.impaxlabs.com or contact us at 1-800-934-6729.Dextroamphetamine Sulfate Extended-Release Capsules are supplied as follows:Dextroamphetamine Sulfate Extended-Release Capsules, 5 mg: “327”“CP”“5 mg”Dextroamphetamine Sulfate Extended-Release Capsules, 10 mg: “328”“CP”“10 mg”Dextroamphetamine Sulfate Extended-Release Capsules, 15 mg: “329”“CP”“15 mg”Store at controlled room temperature between 20° to 25°C (68° to 77°F) [See USP].Dispense in a tight, light-resistant container.Manf. by:Catalent Pharma SolutionsWinchester, KY 40391 Dist. by:Impax GenericsHayward, CA 94544Rev. May, 2017For additional copies of the printed patient information/medication guide, please visit www.impaxlabs.com or contact us at 1-800-934-6729.Dextroamphetamine Sulfate Extended-Release Capsules are supplied as follows:Dextroamphetamine Sulfate Extended-Release Capsules, 5 mg: “327”“CP”“5 mg”Dextroamphetamine Sulfate Extended-Release Capsules, 10 mg: “328”“CP”“10 mg”Dextroamphetamine Sulfate Extended-Release Capsules, 15 mg: “329”“CP”“15 mg”Store at controlled room temperature between 20° to 25°C (68° to 77°F) [See USP].Dispense in a tight, light-resistant container.Manf. by:Catalent Pharma SolutionsWinchester, KY 40391 Dist. by:Impax GenericsHayward, CA 94544Rev. May, 2017For additional copies of the printed patient information/medication guide, please visit www.impaxlabs.com or contact us at 1-800-934-6729.Dextroamphetamine Sulfate Extended-Release Capsules are supplied as follows:Dextroamphetamine Sulfate Extended-Release Capsules, 5 mg: “327”“CP”“5 mg”Dextroamphetamine Sulfate Extended-Release Capsules, 10 mg: “328”“CP”“10 mg”Dextroamphetamine Sulfate Extended-Release Capsules, 15 mg: “329”“CP”“15 mg”Store at controlled room temperature between 20° to 25°C (68° to 77°F) [See USP].Dispense in a tight, light-resistant container.Manf. by:Catalent Pharma SolutionsWinchester, KY 40391 Dist. by:Impax GenericsHayward, CA 94544Rev. May, 2017For additional copies of the printed patient information/medication guide, please visit www.impaxlabs.com or contact us at 1-800-934-6729.Dextroamphetamine Sulfate Extended-Release Capsules are supplied as follows:Dextroamphetamine Sulfate Extended-Release Capsules, 5 mg: “327”“CP”“5 mg”Dextroamphetamine Sulfate Extended-Release Capsules, 10 mg: “328”“CP”“10 mg”Dextroamphetamine Sulfate Extended-Release Capsules, 15 mg: “329”“CP”“15 mg”Store at controlled room temperature between 20° to 25°C (68° to 77°F) [See USP].Dispense in a tight, light-resistant container.Manf. by:Catalent Pharma SolutionsWinchester, KY 40391 Dist. by:Impax GenericsHayward, CA 94544Rev. May, 2017For additional copies of the printed patient information/medication guide, please visit www.impaxlabs.com or contact us at 1-800-934-6729.Dextroamphetamine Sulfate Extended-Release Capsules are supplied as follows:Dextroamphetamine Sulfate Extended-Release Capsules, 5 mg: “327”“CP”“5 mg”Dextroamphetamine Sulfate Extended-Release Capsules, 10 mg: “328”“CP”“10 mg”Dextroamphetamine Sulfate Extended-Release Capsules, 15 mg: “329”“CP”“15 mg”Store at controlled room temperature between 20° to 25°C (68° to 77°F) [See USP].Dispense in a tight, light-resistant container.Manf. by:Catalent Pharma SolutionsWinchester, KY 40391 Dist. by:Impax GenericsHayward, CA 94544Rev. May, 2017For additional copies of the printed patient information/medication guide, please visit www.impaxlabs.com or contact us at 1-800-934-6729.Dextroamphetamine Sulfate Extended-Release Capsules are supplied as follows:Dextroamphetamine Sulfate Extended-Release Capsules, 5 mg: “327”“CP”“5 mg”Dextroamphetamine Sulfate Extended-Release Capsules, 10 mg: “328”“CP”“10 mg”Dextroamphetamine Sulfate Extended-Release Capsules, 15 mg: “329”“CP”“15 mg”Store at controlled room temperature between 20° to 25°C (68° to 77°F) [See USP].Dispense in a tight, light-resistant container.Manf. by:Catalent Pharma SolutionsWinchester, KY 40391 Dist. by:Impax GenericsHayward, CA 94544Rev. May, 2017For additional copies of the printed patient information/medication guide, please visit www.impaxlabs.com or contact us at 1-800-934-6729.Dextroamphetamine Sulfate Extended-Release Capsules are supplied as follows:Dextroamphetamine Sulfate Extended-Release Capsules, 5 mg: “327”“CP”“5 mg”Dextroamphetamine Sulfate Extended-Release Capsules, 10 mg: “328”“CP”“10 mg”Dextroamphetamine Sulfate Extended-Release Capsules, 15 mg: “329”“CP”“15 mg”Store at controlled room temperature between 20° to 25°C (68° to 77°F) [See USP].Dispense in a tight, light-resistant container.Manf. by:Catalent Pharma SolutionsWinchester, KY 40391 Dist. by:Impax GenericsHayward, CA 94544Rev. May, 2017For additional copies of the printed patient information/medication guide, please visit www.impaxlabs.com or contact us at 1-800-934-6729.Dextroamphetamine Sulfate Extended-Release Capsules are supplied as follows:Dextroamphetamine Sulfate Extended-Release Capsules, 5 mg: “327”“CP”“5 mg”Dextroamphetamine Sulfate Extended-Release Capsules, 10 mg: “328”“CP”“10 mg”Dextroamphetamine Sulfate Extended-Release Capsules, 15 mg: “329”“CP”“15 mg”Store at controlled room temperature between 20° to 25°C (68° to 77°F) [See USP].Dispense in a tight, light-resistant container.Manf. by:Catalent Pharma SolutionsWinchester, KY 40391 Dist. by:Impax GenericsHayward, CA 94544Rev. May, 2017For additional copies of the printed patient information/medication guide, please visit www.impaxlabs.com or contact us at 1-800-934-6729.Dextroamphetamine Sulfate Extended-Release Capsules are supplied as follows:Dextroamphetamine Sulfate Extended-Release Capsules, 5 mg: “327”“CP”“5 mg”Dextroamphetamine Sulfate Extended-Release Capsules, 10 mg: “328”“CP”“10 mg”Dextroamphetamine Sulfate Extended-Release Capsules, 15 mg: “329”“CP”“15 mg”Store at controlled room temperature between 20° to 25°C (68° to 77°F) [See USP].Dispense in a tight, light-resistant container.Manf. by:Catalent Pharma SolutionsWinchester, KY 40391 Dist. by:Impax GenericsHayward, CA 94544Rev. May, 2017For additional copies of the printed patient information/medication guide, please visit www.impaxlabs.com or contact us at 1-800-934-6729.Dextroamphetamine Sulfate Extended-Release Capsules are supplied as follows:Dextroamphetamine Sulfate Extended-Release Capsules, 5 mg: “327”“CP”“5 mg”Dextroamphetamine Sulfate Extended-Release Capsules, 10 mg: “328”“CP”“10 mg”Dextroamphetamine Sulfate Extended-Release Capsules, 15 mg: “329”“CP”“15 mg”Store at controlled room temperature between 20° to 25°C (68° to 77°F) [See USP].Dispense in a tight, light-resistant container.Manf. by:Catalent Pharma SolutionsWinchester, KY 40391 Dist. by:Impax GenericsHayward, CA 94544Rev. May, 2017For additional copies of the printed patient information/medication guide, please visit www.impaxlabs.com or contact us at 1-800-934-6729.


×

Clinical Information

Chemical Structure

No Image found
Clinical Pharmacology

Amphetamines are noncatecholamine, sympathomimetic amines with CNS stimulant activity. Peripheral actions include elevations of systolic and diastolic blood pressures and weak bronchodilator and respiratory stimulant action.

There is neither specific evidence that clearly establishes the mechanism whereby amphetamines produce mental and behavioral effects in children, nor conclusive evidence regarding how these effects relate to the condition of the central nervous system.

Dextroamphetamine sulfate extended release capsules are formulated to release the active drug substance in a more gradual fashion than the standard formulation, as demonstrated by blood levels. The formulation has not been shown superior in effectiveness over the same dosage of the standard, noncontrolled-release formulations given in divided doses.

Non-Clinical Toxicology
Advanced arteriosclerosis, symptomatic cardiovascular disease, moderate to severe hypertension, hyperthyroidism, known hypersensitivity or idiosyncrasy to the sympathomimetic amines, glaucoma.Agitated states.Patients with a history of drug abuse.Known hypersensitivity or idiosyncrasy to amphetamine.In patients known to be hypersensitive to amphetamine, or other components of dextroamphetamine sulfate. Hypersensitivity reactions such as angioedema and anaphylactic reactions have been reported in patients treated with other amphetamine products [see Adverse Reactions]

Patients taking monoamine oxidase inhibitors (MAOIs), or within 14 days of stopping MAOIs (including MAOIs such as linezolid or intravenous methylene blue), because of an increased risk of hypertensive crisis [see Warnings and Drug Interactions].

The least amount feasible should be prescribed or dispensed at 1 time in order to minimize the possibility of overdosage.

×

Reference

This information is obtained from the National Institute of Health's Standard Packaging Label drug database.
"https://dailymed.nlm.nih.gov/dailymed/"

While we update our database periodically, we cannot guarantee it is always updated to the latest version.

×

Review

Rate this treatment and share your opinion


Learn about User Reviews

Helpful tips to write a good review:

  1. Only share your first hand experience as a consumer or a care giver.
  2. Describe your experience in the Comments area including the benefits, side effects and how it has worked for you. Do not provide personal information like email addresses or telephone numbers.
  3. Fill in the optional information to help other users benefit from your review.

Reason for Taking This Treatment

(required)

Click the stars to rate this treatment

Effectiveness (required)

This medication has worked for me.




Ease of Use (required)

This medication has been easy for me to use.




Satisfaction (required)

Overall, I have been satisfied with my experience.




Write a brief description of your experience with this treatment:

2000 characters remaining

Optional Information

Help others benefit from your review by filling in the information below.
I am a:
Gender:
×

Professional

Clonazepam Description Each single-scored tablet, for oral administration, contains 0.5 mg, 1 mg, or 2 mg Clonazepam, USP, a benzodiazepine. Each tablet also contains corn starch, lactose monohydrate, magnesium stearate, microcrystalline cellulose, and povidone. Clonazepam tablets USP 0.5 mg contain Yellow D&C No. 10 Aluminum Lake. Clonazepam tablets USP 1 mg contain Yellow D&C No. 10 Aluminum Lake, as well as FD&C Blue No. 1 Aluminum Lake. Chemically, Clonazepam, USP is 5-(o-chlorophenyl)-1,3-dihydro-7-nitro-2H-1,4-benzodiazepin-2-one. It is a light yellow crystalline powder. It has the following structural formula: C15H10ClN3O3 M.W. 315.72
×

Tips

Tips

×

Interactions

Interactions

A total of 440 drugs (1549 brand and generic names) are known to interact with Imbruvica (ibrutinib). 228 major drug interactions (854 brand and generic names) 210 moderate drug interactions (691 brand and generic names) 2 minor drug interactions (4 brand and generic names) Show all medications in the database that may interact with Imbruvica (ibrutinib).